Lightforce Group Competitors

For decades, Synopsys has been delivering breakthroughs in silicon design and IP that have fueled technology innovation. With Ansys now part of Synopsys, we can maximize the capabilities of product R&D teams broadly enabling them to rapidly innovate AI-powered products. We’re best positioned to deliver new, holistic system design solutions for customers in industries spanning semiconductors, high-tech, automotive, aerospace, industrial, and more.

Cimpress plc (Nasdaq: CMPR) invests in and builds customer-focused, entrepreneurial, mass-customization businesses for the long term. Mass customization is a competitive strategy which seeks to produce goods and services to meet individual customer needs with near mass production efficiency. Cimpress is a strategically-focused group of more than a dozen businesses, each operating in a largely autonomous manner other than as it relates to the select few shared strategic and corporate activities that we maintain centrally. Cimpress businesses include Drukwerkdeal, Exaprint, National Pen, Pixartprinting, Printi, Vistaprint and WIRmachenDRUCK. Founded by Robert Keane, who remains President & CEO today, the company has been passionate about empowering people to make an impression through individually meaningful, personalized physical products for more than 20 years. To learn more, visit http://www.cimpress.com.

Despite our rapidly increasing understanding of lung disease, our ability for effective treatments is critically limited by the lack of sophistication previously applied to measuring lung function in a regional manner. Nearly all lung pathologies are associated at the onset of disease with subtle, significant and regional changes in airflow due to changes in tissue compliance and/or resistance. However, the current gold standard diagnostics can only measure pulmonary capacity as an average over the entire lung. As a result, a diagnosis can often come too late because for a loss of lung function to even be measurable, the disease must be well-advanced. Now, for the first time in medical history, the capacity to simply, safely and effectively view and measure regional lung function is here. We are 4DMedical - the medical technology company responsible for the XV Lung Ventilation Analysis Software - the breakthrough lung imaging technology that quantitatively measures the patterns of regional lung function in a four-dimensional and highly visual manner.